Inhibition of SARS-CoV-2 main protease 3CL(pro) by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking

The coronavirus disease infections (COVID-19) caused by a new type of coronavirus (SARS-CoV-2) have been emerging in the entire world. Therefore, it is necessary to find out potential therapeutic pharmaceuticals for this disease. This study investigates the inhibitory effect of the 3-chymotrypsin-li...

Descripción completa

Detalles Bibliográficos
Autor principal: Elzupir, Amin O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347502/
https://www.ncbi.nlm.nih.gov/pubmed/32834113
http://dx.doi.org/10.1016/j.molstruc.2020.128878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347502/
https://www.ncbi.nlm.nih.gov/pubmed/32834113
http://dx.doi.org/10.1016/j.molstruc.2020.128878

Ejemplares similares